Peptides  ›  Hexarelin  ›  Growth Hormone
Growth Hormone

Hexarelin for Growth Hormone: What the Research Says

Preclinical and early human research.Updated August 2026

Hexarelin (also known as Examorelin) is a potent GH secretagogue also studied for cardiac tissue effects. This page covers what the published research does — and does not — establish about it in relation to growth-hormone support.

What the research covers

Hexarelin is researched for Growth hormone release — which is why it appears in discussions of growth-hormone support.

Research status: Preclinical and early human research.

How Hexarelin is thought to work

Hexarelin is a potent growth-hormone-releasing peptide. Beyond stimulating GH, research has examined direct effects on cardiac tissue through the CD36 and ghrelin receptors, making it of interest in cardiovascular studies.

What it does not establish

Potency may lead to receptor desensitization. Endocrine-active.

Nothing on this page is a recommendation to use Hexarelin, and Selpho publishes no dosing, reconstitution or sourcing information. Read how we decide what goes in the library.

Commonly researched alongside

A growth-hormone-releasing hormone analog studied for GH support.

Other peptides researched for Growth Hormone

A growth-hormone-releasing hormone analog studied for GH support.

A selective growth-hormone secretagogue studied for its clean GH-release profile.

One of the earliest GHRH analogs, historically used to assess GH function.

A GHRH analog approved for HIV-associated lipodystrophy and studied for visceral fat.

A growth-hormone-releasing peptide studied as a GH secretagogue.

An early GH-releasing peptide known for strongly stimulating appetite.

An orally active growth-hormone secretagogue (a non-peptide) studied for GH/IGF-1.

Frequently asked questions

Preclinical and early human research. Research relevant to this area covers growth hormone release. That is a description of where the research points, not evidence that it will work for you — and Selpho does not provide dosing or medical advice.

Preclinical and early human research.

Potency may lead to receptor desensitization. Endocrine-active. Always speak to a licensed healthcare professional before considering any peptide.

Growth-hormone release plus cardiac-tissue studies and recovery. Evidence is preclinical and early human research.

It is quite potent, though potency can lead to receptor desensitization over time in studies. It is endocrine-active.

Is Hexarelin right for your situation?

Describe your goals and the free Peptide Advisor will match them against the research — no signup, no sales pitch.

Ask the Advisor — free

This page is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.